DULL; Gary Maurice

Patent Applications and Registrations

Patent applications and USPTO patent grants for DULL; Gary Maurice.The latest application filed is for "synthesis and novel salt forms of (r)-5-((e)-2-pyrrolidin-3-ylvinyl)pyrimidine".

Company Profile

4.47.45

DULL; Gary Maurice - Lewisville NC
Dull; Gary Maurice - Winston-Salem NC US
Dull; Gary Maurice - Lewsiville NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synthesis And Novel Salt Forms Of (r)-5-((e)-2-pyrrolidin-3-ylvinyl)pyrimidine App 20210371401 - AKIREDDY; Srinivasa Rao ; et al.	2021-12-02
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine Grant 10,919,879 - Akireddy , et al. February 16, 2	2021-02-16
Synthesis And Novel Salt Forms Of (r)-5-((e)-2-pyrrolidin-3-ylvinyl)pyrimidine App 20200207740 - AKIREDDY; Srinivasa Rao ; et al.	2020-07-02
Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine Grant 10,421,745 - Akireddy , et al. Sept	2019-09-24
Novel Salt Forms Of (r)-5-((e)-2-pyrrolidin-3-ylvinyl)pyrimidine App 20190071428 - AKIREDDY; Srinivasa Rao ; et al.	2019-03-07
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine Grant 9,981,949 - Akireddy , et al. May 29, 2	2018-05-29
Synthesis And Novel Salt Forms Of (r)-5-((e)-2-pyrrolidin-3-ylvinyl)pyrimidine App 20170260167 - Akireddy; Srinivasa Rao ; et al.	2017-09-14
Synthesis And Novel Salt Forms Of (r)-5-((e)-2-pyrrolidin-3ylvinyl)pyrimidine App 20160046609 - Akireddy; Srinivasa Rao ; et al.	2016-02-18
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine Grant 9,145,396 - Akireddy , et al. September 29, 2	2015-09-29
Arylvinylazacycloalkane Compounds And Methods Of Preparation And Use Thereof App 20150164894 - Schmitt; Jeffrey Daniel ; et al.	2015-06-18
(2s,3r)-n-2-3-pyridinylmethyl-1-azabicyclo 2.2.2 Oct-3-yl Benzofuran-2-carboxamide, Novel Salt Forms, And Methods Of Use Thereof App 20150045386 - Bencherif; Merouane ; et al.	2015-02-12
(2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2- -carboxamide novel salt forms, and methods of use thereof Grant 8,846,715 - Bencherif , et al. September 30, 2	2014-09-30
Process for the preparation of aryl substituted olefinic amines Grant 8,703,802 - Dull , et al. April 22, 2	2014-04-22
Synthesis And Novel Salt Forms Of (r)-3-((e)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine App 20140107163 - Akireddy; Srinvasa Rao ; et al.	2014-04-17
Arylvinylazacycloalkane Compounds And Methods Of Preparation And Use Thereof App 20140107164 - Schmitt; Jeffrey Daniel ; et al.	2014-04-17
Synthesis And Novel Salt Forms Of (r)-5-((e)-2-pyrrolidin-3ylvinyl)pyrimidine App 20140066460 - Akireddy; Srinivasa Rao ; et al.	2014-03-06
(2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzyofurn-- 2-carboxamide, Novel Salt Forms, And Methods Of Use Thereof App 20140024673 - Bencherif; Merouane ; et al.	2014-01-23
Synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine Grant 8,633,227 - Akireddy , et al. January 21, 2	2014-01-21
Arylvinylazacycloalkane compounds and methods of preparation and use thereof Grant 8,633,222 - Schmitt , et al. January 21, 2	2014-01-21
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine Grant 8,604,191 - Akireddy , et al. December 10, 2	2013-12-10
Novel Polymorph Forms Of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine App 20130310425 - Dull; Gary Maurice ; et al.	2013-11-21
(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2- -carboxamide, novel salt forms, and methods of use thereof Grant 8,541,446 - Bencherif , et al. September 24, 2	2013-09-24
New Process for the Preparation of Aryl Substituted Olefinic Amines App 20130225827 - Dull; Gary Maurice ; et al.	2013-08-29
Compounds capable of activating cholinergic receptors Grant 8,288,420 - Caldwell , et al. October 16, 2	2012-10-16
(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-- 2-carboxamide, novel salt forms, and methods of use thereof Grant 8,119,659 - Dull , et al. February 21, 2	2012-02-21
Synthesis and Novel Salt Forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine App 20120015983 - Akireddy; Srinivasa Rao ; et al.	2012-01-19
Arylvinylazacycloalkane compounds and methods of preparation and use thereof Grant 8,063,068 - Schmitt , et al. November 22, 2	2011-11-22
Synthesis And Novel Salt Forms Of (r)-5-((e)-2-pyrrolidin-3ylvinyl)pyrimidine App 20110281895 - Akireddy; Srinivasa Rao ; et al.	2011-11-17
(2s, 3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran- -2-carboxamide, Novel Salt Forms, And Methods Of Use Thereof App 20110263859 - Dull; Gary Maurice ; et al.	2011-10-27
(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzofuran-- 2-carboxamide, novel salt forms, and methods of use thereof Grant 7,981,906 - Dull , et al. July 19, 2	2011-07-19
Arylvinylazacycloalkane Compounds And Methods Of Preparation And Use Thereof App 20110152293 - Schmitt; Jeffrey Daniel ; et al.	2011-06-23
Preparation And Enantiomeric Separation Of 7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane And Novel Salt Forms Of The Racemate And Enantiomers App 20110118239 - Beaver; Jessica ; et al.	2011-05-19
Compounds capable of activating cholinergic receptors Grant 7,790,757 - Caldwell , et al. September 7, 2	2010-09-07
Compounds Capable Of Activating Cholinergic Receptors App 20100222395 - Caldwell; William Scott ; et al.	2010-09-02
Compounds Capable Of Activating Cholinergic Receptors App 20100204481 - Caldwell; William Scott ; et al.	2010-08-12
Pharmaceutical compositions and methods for use Grant RE41,439 - Miller , et al. July 13, 2	2010-07-13
Compounds Capable Of Activating Cholinergic Receptors App 20100160390 - Caldwell; William Scott ; et al.	2010-06-24
Arylvinylazacycloalkane compounds and methods of preparation and use thereof Grant 7,714,001 - Schmitt , et al. May 11, 2	2010-05-11
Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs App 20100028447 - Letchworth; Sharon Rae ; et al.	2010-02-04
Arylvinylazacycloalkane Compounds And Methods Of Preparation And Use Thereof App 20100010042 - Schmitt; Jeffrey Daniel ; et al.	2010-01-14
2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzyofuran-- 2-carboxamide, Novel Salt Forms, And Methods Of Use Thereof App 20090048290 - Bencherif; Merouane ; et al.	2009-02-19
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof App 20080293778 - Schmitt; Jeffrey Daniel ; et al.	2008-11-27
Hydroxybenzoate Salts Of Metanicotine Compounds App 20080249142 - Dull; Gary Maurice ; et al.	2008-10-09
Compounds Capable of Activating Cholinergic Receptors App 20080214628 - Caldwell; William Scott ; et al.	2008-09-04
Compounds Capable of Activating Cholinergic Receptors App 20080139809 - Caldwell; William Scott ; et al.	2008-06-12
Compounds Capable of Activating Cholinergic Receptors Grant 7,307,092 - Caldwell , et al. December 11, 2	2007-12-11
Compounds Capable of Activating Cholinergic Receptors App 20060264445 - Caldwell; William Scott ; et al.	2006-11-23
Pharmaceutical compositions and methods for use Grant 7,101,896 - Dull , et al. September 5, 2	2006-09-05
Arylvinylazacycloalkane compounds and methods of preparation and use thereof Grant 7,098,331 - Schmitt , et al. August 29, 2	2006-08-29
Compounds capable of activating cholinergic receptors Grant 7,060,826 - Caldwell , et al. June 13, 2	2006-06-13
Hydroxybenzoate salts of metanicotine compounds App 20060122238 - Dull; Gary Maurice ; et al.	2006-06-08
Arylvinylazacycloalkane compounds and methods of preparation and use thereof App 20060094732 - Schmitt; Jeffrey Daniel ; et al.	2006-05-04
Compounds capable of activating cholinergic receptors App 20050282846 - Caldwell, Willian Scott ; et al.	2005-12-22
Pharmaceutical compositions and methods for use App 20050267111 - Dull, Gary Maurice ; et al.	2005-12-01
Compounds capable of activating cholinergic receptors Grant 6,958,399 - Caldwell , et al. October 25, 2	2005-10-25
Compounds capable of activating cholinergic receptors App 20050131034 - Caldwell, William Scott ; et al.	2005-06-16
Pharmaceutical compositions and methods for use Grant 6,890,935 - Dull , et al. May 10, 2	2005-05-10
Pharmaceutical compositions and methods for use Grant 6,852,721 - Miller , et al. February 8, 2	2005-02-08
Compounds capable of activating cholinergic receptors App 20040214835 - Caldwell, William Scott ; et al.	2004-10-28
Arylvinylazacycloalkane compounds and methods of preparation and use thereof App 20040176348 - Schmitt, Jeffrey Daniel ; et al.	2004-09-09
Pharmaceutical compositions and methods for use Grant 6,743,812 - Dull June 1, 2	2004-06-01
Pharmaceutical compositions and methods for use Grant 6,627,648 - Dull , et al. September 30, 2	2003-09-30
Pharmaceutical compositions for treating and/or preventing CNS disorders Grant 6,624,173 - Crooks , et al. September 23, 2	2003-09-23
3-pyridinyl compounds Grant 6,603,011 - Caldwell , et al. August 5, 2	2003-08-05
Pharmaceutical compositions and methods for use App 20030087915 - Dull, Gary Maurice ; et al.	2003-05-08
Pyrimidinyl compounds for treatment of central nervous system disorders Grant 6,555,684 - Caldwell , et al. April 29, 2	2003-04-29
Pharmaceutical compositions and methods for use App 20030045523 - Schmitt, Jeffrey Daniel ; et al.	2003-03-06
Pharmaceutical compositions and methods for effecting dopamine release Grant 6,525,065 - Caldwell , et al. February 25, 2	2003-02-25
Pharmaceutical compositions and methods for use Grant 6,492,399 - Dull , et al. December 10, 2	2002-12-10
Pharmaceutical compositions for inhibition of cytokine production and secretion Grant 6,489,349 - Bencherif , et al. December 3, 2	2002-12-03
Oxopyridinyl pharmaceutical compositions and methods for use Grant 6,455,554 - Dull , et al. September 24, 2	2002-09-24
Pharmaceutical compositions and methods for use Grant 6,440,970 - Clark , et al. August 27, 2	2002-08-27
Pharmaceutical compositions and methods for use Grant 6,432,975 - Schmitt , et al. August 13, 2	2002-08-13
Pharmaceutical compositions and methods for use Grant 6,417,359 - Crooks , et al. July 9, 2	2002-07-09
Pharmaceutical compositions and methods for use App 20020058652 - Dull, Gary Maurice ; et al.	2002-05-16
Compounds capable of activating cholinergic receptors App 20020052497 - Caldwell, William Scott ; et al.	2002-05-02
Pharmaceutical compositions for prevention and treatment of central nervous system disorders App 20020032206 - Caldwell, William Scott ; et al.	2002-03-14
Pharmaceutical compositions and methods for use App 20020013309 - Miller, Craig Harrison ; et al.	2002-01-31
Pharmaceutical Compositions And Methods For Use App 20010031771 - DULL, GARY MAURICE ; et al.	2001-10-18
Pharmaceutical Compositions And Methods For Use App 20010014691 - DULL, GARY MAURICE ; et al.	2001-08-16
Methods for prevention and treatment of Tourette's syndrome and schizophrenia Grant 6,107,298 - Bencherif , et al. August 22, 2	2000-08-22
Certain 1-aza-tricyclo [3.3.1-1.sup.3,7 ] decane compounds Grant 6,057,446 - Crooks , et al. May 2, 2	2000-05-02
Methods for prevention and treatment of attention deficit disorder Grant 5,885,998 - Bencherif , et al. March 23, 1	1999-03-23
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds Grant 5,861,423 - Caldwell , et al. January 19, 1	1999-01-19
Pharmaceutical compositions for prevention and treatment of central nervous system disorders Grant 5,824,692 - Lippiello , et al. October 20, 1	1998-10-20
Pharmaceutical compositions for prevention and treatment of central nervous system disorders Grant 5,726,316 - Crooks , et al. March 10, 1	1998-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.